RCKT· Rocket Pharmaceuticals Inc.
Insider buys/sells · last 6 mo · open market only
| Transactions | Total $ | |
|---|---|---|
| Buys | 0 | $0 |
| Sells | 6 | $122K |
Quarterly ownership history
Last 5 quarters
RCKT Financials
Live via yfinance — refreshed daily.
Valuation
Market capitalization$396M
Enterprise value$277M
EV / EBITDA (TTM)-1.37
P/E ratio (TTM)—
Forward P/E-3.13
P/S ratio—
P/B ratio1.42
PEG ratio—
Cash Flow
Operating cash flow (TTM)-$180M
Free cash flow (TTM)-$97M
Total cash$144M
Total debt$25M
Debt / equity10.40
Current ratio6.12
Income Statement
Total revenue (TTM)—
Revenue per share (TTM)—
Gross profit (TTM)—
EBITDA (TTM)-$202M
Net income (TTM)-$209M
EPS diluted (TTM)-1.87
Shares outstanding109,193,549
Float shares88,732,862
Profitability
Gross margin0.00%
Operating margin0.00%
EBITDA margin0.00%
Net margin0.00%
Efficiency
Return on assets (TTM)-35.14%
Return on equity (TTM)-64.41%
Price History
Current price$3.63
52 Week high$7.39
52 Week low$2.19
50 day average$4.06
200 day average$3.56
Average volume (10 day)2,235,210
1-year beta—
1-year price target$9.30
Dividends
Dividend yield—
Dividend rate (annual)—
Payout ratio0.00%
Fundamentals are sourced from yfinance and refreshed daily. Last updated May 10, 2026, 5:41 PM. Empty cells (—) mean yfinance doesn't have that field for this ticker (common for ADRs, recent IPOs, or non-applicable ratios).
Real-time alerts. We'll let you know when a whale you follow files a new 13F, or a stock you follow has insider activity. No weekly digest.
whalstreet
★ WatchlistData from SEC EDGAR · whalstreet.com